Medical Licensing (MD/DO) · Independent exam preparation
European Diploma in Intensive Care Medicine (EDIC) Study Guide
Practise shock assessment, protective ventilation, organ support and safe ICU decisions through 60 focused concepts and original EDIC Part I learning questions.
By CertMedbry · Updated 20 October 2026
Learn to distinguish fluid responsiveness from fluid tolerance, calculate cerebral perfusion pressure, recognise unresolved ketoacidosis and choose interventions that address the cause of deterioration. This guide selects 60 adult intensive care concepts using the published EDIC Part I domain weights. The official CoBaTrICE-based outline defines the full examination scope, including paediatric patients and competencies beyond this selection. The accompanying questions and flashcards are independent learning materials.
Try 20 free practice questionsWhat is the exam format?
Check the question types, timing and outline before planning your revision.
Which EDIC component does this guide prepare for?
This guide follows the written EDIC Part I blueprint. Part I assesses theoretical intensive care knowledge. Part II assesses clinical competencies, expertise and professional conduct near the end of intensive care training. They are components of ESICM's European Diploma in Intensive Care Medicine; both must be passed.
European Diploma in Intensive Care Medicine: Exam Guidelines and Regulations, 2026 — 31/03/2026 version · EDIC — ESICM
How many questions are in Part I, and how long does it last?
Part I contains 100 questions, with three hours to complete the examination. It is conducted in English. The official candidate page states that breaks are not allowed.
Which question styles does the actual examination use?
The handbook describes Type A questions with five options and one best answer, and Type K′ questions requiring a true/false response to each of four statements. It permits a maximum of 50 Type K′ questions. This guide's four-option single-best-answer drills use a different educational format and do not simulate either the complete Part I format or the Part II OSCE.
How are questions scored, and are any designated as pretest questions?
A correct Type A response earns one point. A Type K′ response earns one point for four correct judgments, half a point for three, and zero for fewer than three. The maximum stated score is 100. The handbook does not identify a separate unscored pretest allocation. New and anchoring questions should not be assumed to be unscored; questions may be removed after validity review.
How is Part I delivered, and is it adaptive?
Part I is delivered remotely online with proctoring. Candidates must meet the current technical and examination-environment requirements. The published format specifies 100 questions and does not describe computer-adaptive delivery.
EDIC I Exam — ESICM · European Diploma in Intensive Care Medicine: Exam Guidelines and Regulations, 2026 — 31/03/2026 version
Which blueprint and dates apply to this guide?
The guide uses the EDIC Guidelines 2026, version dated 31/03/2026. No separate effective-from date was stated. Part I weights are Disease management 50%, Therapeutic interventions / Organ system support 30%, Practical procedures 10%, and Patient general care 10%. The guide allocates 30/18/6/6 concepts and 10/6/2/2 questions and flashcards accordingly.
Does this selection cover the whole examination syllabus?
No. The official outline is the full scope: both parts draw on 12 CoBaTrICE competency areas containing 102 statements, with cross-cutting assessment of mechanisms, diagnosis, monitoring, treatment and ICU management in adult and paediatric patients. This adult-focused selection approximates subdomain proportions and must be supplemented with the complete competencies.
How does Part II differ?
The handbook describes an online OSCE with three clinical scenario stations of 25 minutes each and three computer-based interpretation stations of 12 minutes each, plus reading and transition arrangements. It describes an overall assessment lasting at least two hours. Part II uses the same broad blueprint with different domain weighting. The issuer's reference to a two-day assessment should not be interpreted as two full days of testing for every candidate.
European Diploma in Intensive Care Medicine: Exam Guidelines and Regulations, 2026 — 31/03/2026 version · EDIC — ESICM
Who is eligible, and does EDIC replace medical registration?
Part I requires full medical registration after completion of internship; entry into or completion of a national primary-specialty training programme; and entry into a national intensive care medicine training programme or satisfactory completion of 18 months of intensive care medicine training. The handbook states that the second and third criteria are fulfilled if intensive care medicine is recognised as a primary specialty. Part II requires successful completion of Part I and 24 months of intensive care medicine training. EDIC complements postgraduate specialist training; recognition and permission to practise remain jurisdiction-specific.
Is there a fixed passing percentage?
The handbook describes standard setting and statistical anchoring for Part I, rather than a universal fixed passing percentage. Part II uses station-level standard setting and requires passing at least two clinical scenario stations and two computer-based stations. Scores on these learning questions do not predict an EDIC result.
The emphasis is on explaining why a clinical finding changes management: distinguish a physiological response from a treatment indication, identify the population to which a threshold applies, and recognise when an intervention improves one measurement while harming another organ.
Outline used: ESICM EDIC Guidelines 2026, version dated 31/03/2026, linked from the current official EDIC page and opened on 2026-10-10. No separate effective-from date was stated. The workbook label matches the official diploma name. This learning set uses the published Part I domain weights; Part II assesses the same broad blueprint with different weighting.
60 key concepts: understand, apply and avoid the traps
Work through the questions by exam domain. Explain the answer in your own words, try the example, then check the common pitfall.
Disease management50%
1.How does echocardiography distinguish major shock mechanisms?
Shock reflects inadequate tissue perfusion, but hypotension alone does not identify its mechanism. Bedside echocardiography can reveal severe ventricular dysfunction, right ventricular pressure overload, pericardial fluid with tamponade physiology, or a small hyperdynamic ventricle. Interpret these findings alongside history, examination and perfusion markers. The useful decision is whether the dominant problem involves pump function, obstruction, vascular tone or circulating volume, because indiscriminate fluid administration can aggravate some phenotypes.
Apply it
A hypotensive patient develops raised jugular venous pressure and severe right ventricular dilatation. Use these findings to investigate an obstructive or right ventricular process and assess congestion before deciding whether additional fluid could help.
Common pitfall: A hyperdynamic left ventricle does not prove hypovolaemia. Vasodilatation can produce the same appearance, and mixed mechanisms commonly coexist in critically ill patients.
New ESICM Guideline on Circulatory Shock and Haemodynamic Monitoring
2.Why can tissue hypoperfusion persist after blood pressure improves?
Arterial pressure reflects the interaction of flow and vascular resistance; it does not directly measure oxygen delivery to tissues. A patient can have an acceptable pressure while cardiac output remains inadequate or regional perfusion is impaired. Follow capillary refill, skin temperature, mental status, urine output and biochemical trends alongside haemodynamic measurements. Persistent abnormalities should trigger reassessment of the shock mechanism and treatment response rather than automatic escalation toward a higher pressure.
Apply it
After vasopressor treatment, mean arterial pressure improves, but the patient remains mottled with prolonged capillary refill and declining urine output. Reassess cardiac function, perfusion and congestion instead of declaring resuscitation complete from pressure alone.
Common pitfall: Normalising one monitor value can conceal continuing organ hypoperfusion. Conversely, individual peripheral findings can be affected by temperature, drugs and pre-existing disease.
ESICM guidelines on circulatory shock and hemodynamic monitoring 2025 — UCL Discovery · New ESICM Guideline on Circulatory Shock and Haemodynamic Monitoring
3.How does passive leg raising test fluid responsiveness?
Passive leg raising temporarily transfers venous blood centrally without leaving an administered fluid load behind. Compare the immediate stroke-volume or cardiac-output response with a stable pre-test baseline, using a method fast enough to capture the transient effect. A positive response must exceed measurement uncertainty and meet a threshold validated for that measurement method. Blood pressure alone may miss a flow response because pressure also depends on vascular resistance. The test therefore assesses the response of flow to a reversible increase in preload.
Apply it
Aortic flow rises from 4.0 to 4.5 L/min during passive leg raising, a 12.5% increase from baseline. Compare that change with the measurement method's validated criterion, then assess congestion and the need to improve perfusion before administering fluid.
Common pitfall: Any increase is not enough: a small change may be noise. Even a valid positive test establishes preload responsiveness, not that a fluid bolus is necessary or safe.
Surviving Sepsis Campaign Adult Quick Guide, 2026 · New ESICM Guideline on Circulatory Shock and Haemodynamic Monitoring
4.What distinguishes fluid tolerance from fluid responsiveness?
Fluid responsiveness asks whether increasing preload will raise stroke volume. Fluid tolerance asks whether the patient can accept additional volume without clinically important congestion or deterioration in organ function. These are separate questions. Evaluate oxygenation, pulmonary oedema, ventricular function and venous congestion alongside the expected perfusion benefit. When the harm of further fluid exceeds the likely benefit, alternative treatment of vascular tone or cardiac dysfunction may be more appropriate despite a positive responsiveness test.
Apply it
Stroke volume rises during a reversible preload test, but a ventilated patient has worsening oxygenation and marked venous congestion. Recognise potential fluid responsiveness while withholding an automatic bolus and reassessing the dominant cause of circulatory failure.
Common pitfall: Low blood pressure does not guarantee that extra fluid is tolerated. Repeated boluses can worsen gas exchange and congestion without producing a sustained perfusion benefit.
New ESICM Guideline on Circulatory Shock and Haemodynamic Monitoring
5.When should an unstable tachyarrhythmia receive synchronised cardioversion or unsynchronised defibrillation?
Urgent synchronised cardioversion is indicated when a tachyarrhythmia with a pulse causes life-threatening instability and the rhythm permits reliable synchronisation. This includes unstable monomorphic ventricular tachycardia. Features include shock, syncope with severe or ongoing hypotension, myocardial ischaemia, and severe heart failure with pulmonary oedema. Synchronisation times the shock to the R wave, reducing the risk of delivering energy during vulnerable ventricular repolarisation. Sustained polymorphic ventricular tachycardia requires immediate unsynchronised defibrillation, even when a pulse is present: changing QRS morphology prevents reliable synchronisation, so attempting to synchronise can delay lifesaving shock delivery. Provide carefully managed sedation or anaesthesia for conscious patients when feasible without delaying urgent treatment.
Apply it
A patient develops regular monomorphic ventricular tachycardia with a pulse, hypotension and pulmonary oedema: prepare urgent synchronised cardioversion and verify that synchronisation markers consistently identify the R waves. A patient with sustained ventricular tachycardia whose QRS morphology changes from beat to beat requires immediate unsynchronised defibrillation; do not wait for reliable synchronisation.
Common pitfall: A palpable pulse does not make synchronised cardioversion appropriate for sustained polymorphic ventricular tachycardia. Conversely, unstable monomorphic ventricular tachycardia should receive synchronised cardioversion when reliable synchronisation is possible. Establish that the arrhythmia causes the deterioration: compensatory sinus tachycardia from haemorrhage or sepsis requires treatment of its underlying cause. Pulseless ventricular tachycardia requires the cardiac-arrest pathway, including CPR and defibrillation.
Adult Advanced Life Support Guidelines, 2025 — Resuscitation Council UK · Adult%20tachyarrhythmia%20algorithm%20V3%20March%202026.pdf
6.How does wide-QRS high-degree AV block change bradycardia treatment?
High-degree atrioventricular block with a wide QRS suggests disease in the distal conduction system, where increasing sinus-node activity does not reliably restore ventricular conduction. In an unstable patient, RCUK advises against atropine for this pattern because it is ineffective and may worsen the block. Establish early transvenous pacing, using transcutaneous pacing as a bridge when needed. Treatment urgency depends on adverse features such as shock, syncope, myocardial ischaemia or severe heart failure.
Apply it
An adult has complete heart block, a broad ventricular escape rhythm and recurrent syncope with hypotension. Prepare urgent pacing and expert support rather than spending repeated treatment cycles on atropine while the unreliable escape rhythm persists.
Common pitfall: A visible ventricular escape rhythm does not establish adequate perfusion or electrical stability. Repeated atropine must not delay pacing in this pattern, and pacing effectiveness requires assessment of both electrical capture and the patient's circulation.
Adult Advanced Life Support Guidelines, 2025 — Resuscitation Council UK
7.What criteria establish acute kidney injury?
The published KDIGO criteria identify AKI through a creatinine increase of at least 0.3 mg/dL within 48 hours, an increase to at least 1.5 times baseline within seven days, or urine output below 0.5 mL/kg/hour for six hours. Either creatinine or urine output can establish the diagnosis. Creatinine may lag behind injury and can be diluted by fluid accumulation. Use both measures and investigate reversible causes rather than waiting for severe azotaemia.
Apply it
A 70 kg adult produces 25 mL of urine hourly for seven hours despite a creatinine still near baseline. The urine-output criterion establishes AKI and warrants assessment of perfusion, obstruction, medicines and measurement accuracy.
Common pitfall: A normal-range creatinine does not exclude AKI when baseline values are lower or oliguria meets criteria. Do not require both diagnostic pathways to be positive.
KDIGO Clinical Practice Guideline for Acute Kidney Injury, 2012
8.How is AKI severity staged when criteria disagree?
Use the most severe stage reached by either creatinine or urine-output criteria. In adults, a creatinine increase to twice baseline meets stage 2, while three times baseline meets stage 3. Urine output below 0.3 mL/kg/hour for at least 24 hours or anuria for at least 12 hours also meets stage 3. Severity classification describes risk and guides monitoring; it does not independently determine whether kidney replacement therapy must begin immediately.
Apply it
Creatinine rises from 1.0 to 2.1 mg/dL, but the patient has also been anuric for 13 hours. Classify the episode as stage 3 because the urine-output criterion is more severe than the creatinine criterion.
Common pitfall: Averaging discordant criteria understates severity. Conversely, a high AKI stage alone is not equivalent to a life-threatening indication for immediate kidney replacement therapy.
KDIGO Clinical Practice Guideline for Acute Kidney Injury, 2012
9.When does AKI require emergency kidney replacement therapy?
Emergency kidney replacement therapy is indicated for life-threatening disturbances of fluid, electrolyte or acid-base balance that cannot be controlled adequately by other measures. Examples include refractory hyperkalaemia, severe refractory acidaemia and pulmonary oedema causing serious respiratory compromise. Assess the whole clinical trajectory, including urine output and complications. A particular creatinine or urea concentration alone is insufficient: the urgency comes from physiological danger and failure of suitable temporising or definitive medical treatment.
Apply it
An oliguric patient has recurrent severe hyperkalaemia despite temporising treatment and worsening pulmonary oedema. Arrange urgent kidney replacement therapy while continuing immediate stabilisation, rather than waiting for creatinine to cross an arbitrary numerical threshold.
Common pitfall: Temporarily shifting potassium into cells does not remove it from the body. A transient improvement can conceal ongoing danger when excretion remains severely impaired.
KDIGO Clinical Practice Guideline for Acute Kidney Injury, 2012
10.How is cerebral perfusion pressure calculated?
Cerebral perfusion pressure is commonly calculated as mean arterial pressure minus intracranial pressure when the relevant pressures are measured consistently. It estimates the pressure gradient available to drive cerebral blood flow, rather than measuring flow directly. In severe traumatic brain injury, Brain Trauma Foundation guidance supports a CPP target between 60 and 70 mmHg, with the appropriate point influenced by autoregulatory status. Both falling arterial pressure and rising intracranial pressure can threaten perfusion.
Apply it
A patient with severe TBI has mean arterial pressure of 88 mmHg and intracranial pressure of 23 mmHg. CPP is 65 mmHg. Recognise acceptable CPP within the recommended range while addressing the independently elevated intracranial pressure.
Common pitfall: An acceptable CPP does not make elevated ICP harmless. Raising arterial pressure indefinitely can create systemic complications and does not replace assessment of intracranial pathology.
Guidelines for the Management of Severe Traumatic Brain Injury, Fourth Edition
11.When should elevated intracranial pressure trigger treatment?
For severe traumatic brain injury, the Brain Trauma Foundation recommends treating ICP above 22 mmHg because higher pressures are associated with increased mortality. Interpret the value with its duration, waveform quality, examination and imaging. A sustained pathological rise differs from a brief artefact during coughing or care. Treatment should address the cause and support cerebral perfusion, using coordinated measures rather than pursuing a monitor value without checking whether it represents a real intracranial problem.
Apply it
ICP remains at 26 mmHg after suctioning has ended, with a valid waveform and new neurological deterioration. Reassess immediately for secondary injury and treat intracranial hypertension while preserving oxygenation, arterial pressure and cerebral perfusion.
Common pitfall: Treating artefactual spikes can expose patients to unnecessary therapy. Dismissing a persistent elevation because CPP remains adequate can also permit harmful intracranial hypertension.
Guidelines for the Management of Severe Traumatic Brain Injury, Fourth Edition
12.Why can prophylactic hyperventilation worsen brain injury?
Lowering arterial carbon dioxide causes cerebral vasoconstriction, which can reduce intracranial blood volume and ICP but also reduce cerebral blood flow. This creates a risk of cerebral ischaemia, especially early after severe TBI when flow may already be reduced. Prolonged prophylactic hyperventilation to PaCO2 of 25 mmHg or less is not recommended. Temporary hyperventilation may serve as a bridge during acute deterioration, while definitive treatment proceeds and cerebral oxygenation is considered.
Apply it
A newly admitted severe TBI patient has stable ICP and PaCO2 of 38 mmHg. Maintain an appropriate ventilation strategy rather than deliberately reducing PaCO2 to 24 mmHg to prevent a possible future pressure rise.
Common pitfall: A lower ICP after hyperventilation does not prove improved brain oxygen delivery. The pressure benefit may occur at the cost of reduced cerebral perfusion.
Guidelines for the Management of Severe Traumatic Brain Injury, Fourth Edition
13.What does current guidance establish about antipsychotics for ICU delirium?
The 2025 focused PADIS update could not recommend for or against antipsychotics over usual care for treating adult ICU delirium because the evidence is insufficient. A delirium diagnosis therefore does not automatically establish an indication for a scheduled antipsychotic or prove that it will shorten delirium. Distinguish treatment of an immediately troublesome symptom from evidence that a drug modifies the underlying syndrome.
Apply it
A patient with delirium is calm and safely participating in care. Do not start scheduled antipsychotics solely on the claim that current guidance establishes faster delirium resolution.
Common pitfall: No recommendation is neither proof of benefit nor a prohibition on every individual use; the proposed therapeutic purpose must be explicit.
A Focused Update to SCCM PADIS Guidelines for Adult Patients, 2025
14.When are antibiotics indicated in acute pancreatitis?
Acute pancreatitis produces sterile inflammation that can cause fever, leucocytosis and organ dysfunction without bacterial infection. Antibiotics are indicated for a demonstrated or strongly suspected infection, including infected pancreatic necrosis or an extrapancreatic source. Routine prophylaxis for sterile necrosis is not recommended. Distinguish the presence of necrosis from infection within it, and assess new deterioration for plausible infectious and non-infectious causes rather than equating inflammatory severity with an automatic antimicrobial indication.
Apply it
CT shows pancreatic necrosis in a patient whose circulation and inflammatory markers are improving, without evidence of infection. Continue supportive care and surveillance rather than starting prophylactic antibiotics solely because necrotic tissue is visible.
Common pitfall: Fever and leucocytosis are not specific for infected necrosis. Conversely, new deterioration warrants reassessment even when earlier imaging and cultures did not demonstrate infection.
15.When can oral feeding resume in mild pancreatitis?
In mild acute pancreatitis, early oral feeding as tolerated is preferred to prolonged fasting. The ACG highlights support starting within 24–48 hours, with a low-fat solid diet rather than requiring a staged progression through clear liquids. Clinical tolerance matters more than normalisation of pancreatic enzymes. Persistent vomiting, ileus or severe illness changes the route and pace of nutritional support, so the mild-pancreatitis recommendation should not be applied indiscriminately to an unstable ICU patient.
Apply it
A patient with mild pancreatitis is comfortable, hungry and no longer vomiting the day after admission, although lipase remains elevated. Offer tolerated low-fat solid food rather than waiting for the enzyme concentration to return to normal.
Common pitfall: Biochemical recovery need not precede feeding. However, applying an early oral diet to a patient with persistent vomiting or unsafe swallowing ignores essential tolerance and safety boundaries.
16.How does active upper gastrointestinal bleeding change enteral feeding?
ESPEN advises delaying enteral nutrition during active upper gastrointestinal bleeding. Enteral feeding can begin when bleeding has stopped and there are no signs of rebleeding. The decisive distinction is active haemorrhage versus a clinically established recovery phase, rather than whether bleeding occurred at any earlier point in the admission. Reassess ongoing blood loss and the clinical course before restarting nutrition, then select a route and delivery rate appropriate to the patient's condition and feeding tolerance.
Apply it
A patient has continuing bloody gastric output during treatment of an upper gastrointestinal haemorrhage. Withhold enteral feeding during active bleeding. After haemostasis, reassess for recurrent bleeding and resume appropriate nutrition when the recovery criteria are satisfied.
Common pitfall: An elapsed interval alone does not establish haemostasis. Conversely, a previous bleeding episode does not justify indefinite fasting after bleeding has stopped and there are no signs of recurrence.
ESPEN practical and partially revised guideline: Clinical nutrition in the intensive care unit, 2023
17.What distinguishes ARDS from isolated hydrostatic pulmonary oedema?
ARDS involves acute inflammatory lung injury with increased permeability, impaired gas exchange and bilateral pulmonary abnormalities. Under the Berlin framework discussed in ESICM guidance, respiratory deterioration occurs within one week of an insult or new symptoms, with opacities not fully explained by effusions, collapse or nodules. Respiratory failure must not be fully explained by cardiac failure or fluid overload. Cardiac disease can coexist, so the task is to assess whether hydrostatic mechanisms fully explain the presentation.
Apply it
After pneumonia, a ventilated patient develops bilateral opacities and substantial hypoxaemia without left ventricular failure sufficient to explain them. Consider ARDS while assessing any additional fluid overload that could worsen oxygenation and complicate respiratory management.
Common pitfall: Bilateral opacities alone do not establish ARDS. An elevated filling pressure or cardiac history also does not automatically exclude a concurrent inflammatory permeability injury.
18.How does the PaO2/FiO2 ratio describe oxygenation impairment?
Divide arterial oxygen tension in mmHg by inspired oxygen expressed as a fraction. Berlin mild ARDS has a ratio above 200 through 300 with PEEP or CPAP at least 5 cmH2O; noninvasive CPAP is permitted in this category. Moderate ARDS has a ratio above 100 through 200, and severe ARDS a ratio of 100 or less; these categories require invasive ventilation with PEEP at least 5 cmH2O. Timing, imaging and exclusion of a fully hydrostatic explanation remain necessary.
Apply it
During invasive ventilation, PaO2 is 80 mmHg on FiO2 0.50 and PEEP 8 cmH2O. The ratio is 160, within the moderate Berlin category if the other diagnostic criteria are met.
Common pitfall: Use FiO2 0.50, not 50. A low ratio alone cannot establish ARDS, and the mild category's allowance for noninvasive CPAP must not be extended to moderate or severe Berlin ARDS.
19.Why is tidal volume based on predicted body weight?
Lung size relates more closely to height and sex-based predicted body weight than to actual body mass. In ARDS, aerated lung volume is further reduced, making excessive tidal volume particularly injurious. ESICM guidance supports low tidal volumes, generally 4–8 mL/kg predicted body weight, with attention to plateau pressure. Obesity therefore does not justify proportionally larger breaths. Start with a protective calculation and reassess gas exchange, respiratory mechanics and synchrony rather than treating a calculated volume as immutable.
Apply it
A patient weighs 110 kg but has predicted body weight of 60 kg. A starting tidal volume of 6 mL/kg is 360 mL, followed by assessment of plateau pressure, ventilation and patient–ventilator interaction.
Common pitfall: Using actual weight in obesity can substantially overestimate appropriate tidal volume. Normal oxygen saturation does not show that the delivered mechanical stress is safe.
20.When does prone positioning improve ARDS management?
Prone positioning redistributes ventilation and mechanical stress, improving matching between ventilation and perfusion while reducing regional overdistension and collapse. ESICM recommends early prolonged proning for invasively ventilated ARDS when PaO2/FiO2 remains below 150 mmHg with PEEP at least 5 cmH2O despite optimised ventilation. Sessions should last at least 16 consecutive hours. The indication rests on the persistent severity of respiratory failure, rather than waiting until oxygenation has reached an immediately catastrophic level.
Apply it
After protective ventilation is established, PaO2/FiO2 remains 120 on PEEP of 10 cmH2O. Organise an early prolonged prone session with a trained team, airway protection and pressure-area care rather than reserving proning for final rescue.
Common pitfall: A short turn that briefly improves saturation is not equivalent to a prolonged prone strategy. The intervention requires coordinated safety measures and continued protective ventilation.
21.Why can aggressive recruitment manoeuvres harm an ARDS patient?
Recruitment manoeuvres raise airway pressure to reopen collapsed units, but the same pressure can overdistend aerated lung and reduce venous return. The balance depends on recruitability and cardiovascular reserve. ESICM recommends against prolonged high-pressure recruitment manoeuvres and does not support routine brief high-pressure manoeuvres. Improved oxygenation alone is an insufficient justification when haemodynamics deteriorate or injurious stress increases. Distinguish an individual PEEP assessment from indiscriminate exposure to high recruitment pressures.
Apply it
During a high-pressure recruitment attempt, oxygenation improves slightly but arterial pressure falls markedly. Recognise the adverse cardiovascular effect and stop the harmful manoeuvre rather than judging success solely from the arterial oxygen response.
Common pitfall: Opening some lung units does not guarantee net benefit. Concurrent overdistension and circulatory compromise can outweigh a visually reassuring improvement in oxygenation or compliance.
22.How does suspected sepsis change the initial diagnostic approach?
Sepsis requires attention to both infection and resulting organ dysfunction. Assess the likely source, haemodynamic state, respiratory failure, mental status and renal function while considering plausible non-infectious mimics. Diagnostic investigation and treatment often proceed together when illness is severe. The discriminating issue is whether infection plausibly explains the acute dysfunction, not whether fever is present. Reassessment remains essential because the initial probability of infection can increase or decrease as clinical, microbiological and imaging information develops.
Apply it
A patient with suspected pneumonia becomes confused, hypoxaemic and oliguric despite only a modest temperature rise. Evaluate and treat possible infection-associated organ dysfunction promptly while considering alternative explanations for the deterioration and obtaining appropriate diagnostic specimens.
Common pitfall: Requiring high fever can delay recognition. Conversely, labelling every critically ill patient with inflammation as septic can obscure haemorrhage, cardiogenic shock or other important mimics.
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026
23.How should cultures, infection likelihood and shock determine antimicrobial timing?
Obtain appropriate cultures before antimicrobials when feasible without delaying urgent treatment. The 2026 Surviving Sepsis Campaign recommends immediate antimicrobials, ideally within one hour, for possible, probable or definite septic shock and for probable or definite sepsis without shock. For possible sepsis without shock, rapidly investigate infectious and noninfectious explanations. If concern for infection persists after this assessment, the guideline conditionally suggests administering antimicrobials within three hours of first suspicion. When infection likelihood is low and shock is absent, antimicrobial treatment may be deferred with close monitoring and reassessment. Cultures support pathogen identification and subsequent targeted treatment, but sampling must not obstruct urgent therapy.
Apply it
In probable septic shock, draw blood cultures while preparing antimicrobials and resuscitating the patient; administer treatment immediately, ideally within one hour, without waiting for a difficult additional specimen. If possible sepsis without shock is first suspected at 14:00 and infection remains a concern after rapid assessment, administer antimicrobials within the window ending at 17:00. This is a treatment boundary, not an instruction to wait until the deadline. If infection becomes probable or shock develops, use the immediate-treatment branch.
Common pitfall: The three-hour window begins at first suspicion, not after investigations finish. Rapid investigation must lead to an explicit treatment decision. Absence of shock does not justify delay when sepsis is probable or definite. Deferral is appropriate only when infection likelihood is low and shock is absent, with close monitoring for deterioration and repeated assessment of the diagnosis. Continue source investigation even when antimicrobials must precede complete sampling.
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026
24.Why is source control separate from antimicrobial selection?
Antimicrobials may not eradicate infection when an abscess remains undrained, infected material remains in place or contamination continues. Source control removes the anatomical driver through drainage, debridement, device removal or correction of a leak. For sepsis or septic shock requiring source control, the 2026 Surviving Sepsis Campaign conditionally suggests early rather than late intervention, ideally within six hours of diagnosis. This is a guideline recommendation rather than an inflexible deadline. Coordinate intervention with resuscitation and select an effective approach that addresses the focus without avoidable delay.
Apply it
A patient with an infected obstructed urinary system remains shocked despite appropriate antimicrobials. Arrange urgent urinary drainage while continuing haemodynamic resuscitation. Prioritise relief of the obstruction and drainage of infection, aiming for early source control, ideally within six hours of diagnosis, rather than repeatedly broadening antibiotics while the obstruction persists.
Common pitfall: Persistent shock does not automatically indicate antimicrobial resistance. Microbiologically active drugs cannot reliably compensate for an undrained or continuously contaminated focus. The six-hour recommendation should encourage coordinated action; it does not justify waiting until six hours have elapsed or postponing all planning until resuscitation is complete.
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026
25.Which clues justify broader empirical resistant-pathogen coverage?
Empirical coverage should reflect the suspected source, illness severity, prior microbiology, recent antimicrobial exposure and local resistance patterns. Previous colonisation or infection with a resistant organism may be more informative than the nonspecific fact of ICU admission. Broader coverage is justified when the probability and consequence of missing a resistant pathogen are substantial. Reassess that choice as results arrive, because broad initial treatment is a risk-based decision rather than a commitment to maintain maximal spectrum.
Apply it
A patient with septic shock has recent cultures documenting a resistant Gram-negative organism and recent relevant antimicrobial exposure. Incorporate that history and local susceptibility data when choosing empirical treatment, then revise coverage when current cultures clarify the cause.
Common pitfall: ICU location alone is an inadequate reason for every available antimicrobial. Conversely, ignoring documented resistant-organism history can leave a critically ill patient without active initial therapy.
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026
26.When should antimicrobial treatment be narrowed or stopped?
Reassess antimicrobials using microbiology, source control, clinical trajectory and the continuing probability of infection. Narrowing spectrum reduces unnecessary exposure while retaining treatment active against the identified pathogen. If a convincing non-infectious explanation emerges and infection becomes unlikely, discontinuation may be appropriate. Negative cultures alone do not prove absence of infection, especially after prior treatment. The central decision is whether each drug still has a justified target, rather than whether the initial empirical plan was reasonable.
Apply it
Cultures identify a susceptible organism after drainage of an abscess, and the patient improves. Replace unnecessary broad combination coverage with appropriate targeted treatment, using the clinical course and source control to guide the remaining duration.
Common pitfall: Improvement is not a reason to preserve redundant coverage indefinitely. Equally, automatic discontinuation based only on negative cultures can overlook a clinically established infection.
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026
27.How should new fever guide assessment for central-catheter infection?
Fever is not specific for catheter-related infection. CDC advises against removing a central catheter because of fever alone; assess evidence of infection elsewhere, the patient's severity, catheter findings and microbiological information. The decision differs between an isolated temperature rise in a stable patient with another plausible source and deterioration in which an infected device is strongly suspected. A catheter's presence creates a possible source, not a diagnosis.
Apply it
A stable patient with a central catheter develops fever and a convincing new pulmonary infectious focus. Investigate the pulmonary source and assess the catheter rather than automatically attributing the fever to the line.
Common pitfall: Neither automatic removal for every fever nor automatic retention of a suspected infected device is sound source assessment.
Summary of Recommendations: Prevention of Intravascular Catheter-Related Infections — CDC
28.What biochemical findings establish diabetic ketoacidosis?
The 2024 consensus requires diabetes or glucose at least 200 mg/dL, ketosis with beta-hydroxybutyrate at least 3.0 mmol/L or urine ketones at least 2+, and metabolic acidosis with pH below 7.3 or bicarbonate below 18 mmol/L. All three components are required. A history of diabetes permits diagnosis despite a lower glucose concentration. This matters particularly with euglycaemic presentations, where relying on marked hyperglycaemia can miss clinically important ketoacidosis.
Apply it
A patient with diabetes taking an SGLT2 inhibitor has glucose 170 mg/dL, beta-hydroxybutyrate 5 mmol/L and pH 7.20. Recognise DKA despite modest glucose and initiate an appropriate monitored treatment pathway after assessing potassium and volume status.
Common pitfall: Marked hyperglycaemia is not obligatory when diabetes is established. Ketosis without acidosis, however, does not by itself satisfy the complete DKA diagnostic criteria.
Hyperglycemic Crises in Adults With Diabetes: A Consensus Report, 2024
29.How is resolution of DKA distinguished from glucose correction?
DKA resolution requires plasma ketones below 0.6 mmol/L plus venous pH at least 7.3 or bicarbonate at least 18 mmol/L; glucose should ideally also be below 200 mg/dL. Glucose often improves before ketogenesis has resolved. Urinary ketones are unsuitable for determining recovery because beta-hydroxybutyrate converts to acetoacetate during treatment, potentially sustaining or increasing urine positivity. Hyperchloraemic acidosis can also make the anion gap misleading as a resolution criterion.
Apply it
After treatment, glucose is 175 mg/dL but beta-hydroxybutyrate remains 2.2 mmol/L. Continue treatment directed at ketone clearance with appropriate dextrose and electrolyte monitoring rather than stopping insulin solely because glucose has reached the desired range.
Common pitfall: Persistent urinary ketones need not mean worsening DKA. Conversely, normal glucose can coexist with clinically important residual ketonaemia requiring continued insulin and monitoring.
Hyperglycemic Crises in Adults With Diabetes: A Consensus Report, 2024
30.When is a restrictive red-cell transfusion strategy appropriate?
For most haemodynamically stable hospitalised adults, AABB guidance supports considering red-cell transfusion when haemoglobin is below 7 g/dL. This is a consideration threshold, not an instruction to transfuse every patient at a particular number or to ignore clinical deterioration above it. Active bleeding, symptoms, comorbidities and the broader oxygen-delivery problem matter. Some surgical and cardiovascular populations have different supported thresholds, so identify the population before applying a general restrictive strategy.
Apply it
A stable, non-bleeding ICU patient has haemoglobin 7.4 g/dL without ischaemic symptoms. Assess the cause and trajectory of anaemia rather than transfusing automatically to restore a normal laboratory haemoglobin concentration or reach 10 g/dL.
Common pitfall: Restrictive thresholds from stable populations should not be applied mechanically to uncontrolled haemorrhage. Haemoglobin may initially underestimate the severity of acute whole-blood loss.
Therapeutic interventions / Organ system support30%
31.Why is norepinephrine the first-line vasopressor in septic shock?
Septic vasodilatation can reduce vascular tone enough that adequate perfusion pressure cannot be maintained by fluid assessment and treatment alone. Norepinephrine predominantly increases vascular tone through alpha-adrenergic effects, with some beta-adrenergic activity, and is the recommended first-line vasopressor. Titrate it to the patient's pressure and perfusion response while addressing infection and other shock mechanisms. A rising dose is a reason for reassessment, not proof that the remaining problem is simply insufficient vasoconstriction.
Apply it
A patient with septic shock remains hypotensive after initial resuscitation and has no evidence that more fluid is likely to help. Start and titrate norepinephrine while reassessing perfusion, cardiac function, source control and the overall response.
Common pitfall: Vasopressors support circulation but do not replace infection treatment or source control. Achieving a pressure target can conceal persisting low flow or regional hypoperfusion.
32.How should a therapeutic fluid challenge be judged?
A fluid challenge is a treatment trial with a defined physiological aim, not merely an amount of fluid to complete. Specify the expected improvement in flow or perfusion, assess it promptly and look for harm. A meaningful response might include improved stroke volume with better peripheral perfusion, whereas new congestion argues against repetition. Because any benefit may be transient, subsequent boluses need fresh justification rather than relying on the response to an earlier administration.
Apply it
Following a monitored bolus, cardiac output barely changes and oxygen requirements increase. Conclude that the challenge has not produced a favourable benefit–harm balance, stop automatic repetition and reassess alternative support for the underlying circulatory problem.
Common pitfall: Finishing a prescribed volume is not evidence of successful resuscitation. A transient rise in blood pressure alone can overstate the sustained benefit of additional fluid.
New ESICM Guideline on Circulatory Shock and Haemodynamic Monitoring
33.Why are balanced crystalloids often favoured during sepsis resuscitation?
Crystalloids expand extracellular fluid, but their electrolyte composition influences acid-base balance. Large volumes of chloride-rich saline can produce hyperchloraemic metabolic acidosis, complicating interpretation of persistent acidaemia. Sepsis guidance favours balanced crystalloids over saline for many adults requiring resuscitation. Fluid composition does not remove the need to assess whether volume is beneficial: an excessive balanced-crystalloid load can still cause pulmonary oedema, venous congestion and dilution of laboratory measurements.
Apply it
During resuscitation, a patient develops rising chloride and persistent non-anion-gap acidosis after substantial saline exposure. Consider the fluid contribution and the suitability of a balanced crystalloid if further volume is indicated, while reassessing ongoing fluid need.
Common pitfall: Choosing a balanced solution does not make liberal fluid administration harmless. Acid-base effects and volume-related injury are separate considerations that both require clinical reassessment.
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026
34.Why can potassium replacement take priority over insulin in DKA?
DKA causes substantial total-body potassium depletion even when the presenting serum concentration is normal or elevated. Insulin and correction of acidosis move potassium into cells, potentially causing dangerous hypokalaemia. The 2024 consensus recommends delaying insulin when potassium is below 3.5 mmol/L until replacement raises it above that level. Renal function, urine output and serial measurements guide replacement safety. The immediate decision is to prevent an avoidable arrhythmic complication while preparing definitive treatment of ketogenesis.
Apply it
An adult with confirmed DKA has potassium 3.1 mmol/L before insulin begins. Start monitored potassium replacement and delay insulin until potassium is safely corrected, while continuing appropriate fluid assessment and close biochemical surveillance.
Common pitfall: A normal initial potassium does not mean stores are adequate. Starting insulin in significant hypokalaemia can worsen the deficit rapidly and provoke life-threatening arrhythmia.
Hyperglycemic Crises in Adults With Diabetes: A Consensus Report, 2024
35.When should dextrose be added during DKA treatment?
Insulin must continue long enough to suppress ketogenesis and resolve ketoacidosis, but glucose generally falls before that process is complete. The adult consensus recommends adding 5–10% dextrose when glucose falls below 250 mg/dL, alongside adjustment of insulin according to the treatment pathway. This permits continued metabolic treatment while reducing hypoglycaemia risk. Decisions should follow glucose, ketones, acid-base status and potassium together, because each represents a different component of recovery and treatment safety.
Apply it
Glucose falls to 220 mg/dL while beta-hydroxybutyrate remains 3 mmol/L. Add dextrose-containing fluid and continue appropriately adjusted insulin with potassium monitoring rather than stopping treatment while substantial ketonaemia remains unresolved.
Common pitfall: Dextrose during DKA treatment is not evidence that insulin has failed. It allows insulin to continue safely after glucose improves but ketogenesis remains active.
Hyperglycemic Crises in Adults With Diabetes: A Consensus Report, 2024
36.When is bicarbonate considered in DKA?
Routine bicarbonate does not address the insulin deficiency driving ketogenesis and can introduce complications, including worsening hypokalaemia. Fluids, insulin and electrolyte management usually correct the acidosis. The 2024 adult consensus reserves consideration of bicarbonate for severe acidosis with pH below 7.0. The decision therefore depends on the degree of acidaemia and physiological context, rather than the mere presence of a low bicarbonate concentration on the initial blood gas.
Apply it
A patient with DKA has pH 7.18 and bicarbonate 10 mmol/L without another indication for alkali. Treat the underlying ketoacidosis with fluids, insulin and electrolyte management rather than adding bicarbonate solely because the bicarbonate concentration is low.
Common pitfall: A low serum bicarbonate is part of DKA and is not itself an alkali indication. Bicarbonate can worsen potassium-related risk during metabolic treatment.
Hyperglycemic Crises in Adults With Diabetes: A Consensus Report, 2024
37.How does intravenous-to-subcutaneous insulin overlap prevent DKA relapse?
Intravenous insulin has a short-lived effect, whereas subcutaneous insulin requires time to provide reliable coverage. After DKA has resolved and the patient is ready for transition, the adult consensus recommends one to two hours of overlap between subcutaneous insulin administration and stopping the intravenous infusion. Plan the regimen around previous treatment, nutritional intake and hypoglycaemia risk. The purpose is continuous suppression of ketogenesis, not simply replacing one prescription with another at the same clock time.
Apply it
A patient's DKA has resolved and oral intake is reliable. Administer the planned subcutaneous insulin before stopping intravenous insulin, allowing the recommended overlap and checking that the ongoing regimen includes appropriate basal coverage and monitoring.
Common pitfall: Stopping an infusion before subcutaneous insulin becomes effective creates a treatment gap. Normal glucose at transition does not protect against renewed ketogenesis from inadequate insulin coverage.
Hyperglycemic Crises in Adults With Diabetes: A Consensus Report, 2024
38.How should transfusion thresholds change with the clinical population?
Transfusion guidance differentiates stable general medical patients from selected surgical and cardiovascular populations. AABB supports considering thresholds of 7.5 g/dL in cardiac surgery and 8 g/dL in orthopaedic surgery or pre-existing cardiovascular disease, alongside clinical context. These are population-specific options, not interchangeable universal rules. Identify active bleeding, symptoms and the relevant evidence base before selecting a threshold; the general stable-adult recommendation should not be extrapolated automatically to acute myocardial infarction or uncontrolled haemorrhage.
Apply it
Two stable patients each have haemoglobin 7.7 g/dL: one has no cardiovascular disease, while the other is recovering from orthopaedic surgery with established cardiovascular disease. Consider the relevant population guidance and symptoms rather than imposing one identical numerical trigger.
Common pitfall: A single transfusion threshold does not fit every population. Equally, a cardiovascular history does not justify routinely transfusing to a normal haemoglobin concentration.
39.When may dexmedetomidine be preferred to propofol for ICU sedation?
The focused PADIS update suggests dexmedetomidine over propofol for mechanically ventilated adults when light sedation or delirium reduction is a particularly high priority. This is a conditional choice tied to the therapeutic goal, rather than a universal preference for every ventilated patient. Set a sedation target and reassess pain, agitation, haemodynamics and the need for deeper sedation. Drug selection should support the intended level of interaction while accounting for clinically important adverse effects and contraindications.
Apply it
A ventilated patient is approaching liberation and needs comfortable, interactive light sedation. Consider dexmedetomidine in line with the stated goal, while assessing heart rate, blood pressure, analgesia needs and whether deeper sedation is required for another indication.
Common pitfall: A recommendation for light-sedation priorities does not make one drug optimal for all ICU situations. Sedation choice also cannot replace assessment and treatment of pain.
A Focused Update to SCCM PADIS Guidelines for Adult Patients, 2025
40.How can low tidal volume ventilation be adjusted without abandoning protection?
Low tidal volume ventilation reduces injurious stretch, but the resulting carbon dioxide level and pH may require adjustment of respiratory rate, dead space and other reversible contributors. ESICM supports a protective range rather than a single immutable volume. Assess plateau pressure and patient–ventilator interaction while making changes. The aim is adequate ventilation with limited lung stress; immediately returning to a large tidal volume merely to normalise PaCO2 can trade a laboratory improvement for additional ventilator-induced injury.
Apply it
After tidal volume is reduced for ARDS, PaCO2 rises and pH falls modestly. Check respiratory rate, expiratory time, circuit dead space and mechanics before increasing tidal volume beyond the protective strategy solely to normalise the blood gas.
Common pitfall: Normal PaCO2 is not the only treatment goal. Permissive hypercapnia also requires context, especially when conditions such as intracranial hypertension make rising carbon dioxide hazardous.
41.How should higher PEEP be evaluated in moderate-to-severe ARDS?
ESICM recommendation 6.1 makes no recommendation for or against routine higher versus lower PEEP/FiO2 titration to reduce ARDS mortality. Individual consideration of higher PEEP is therefore a physiological assessment, not an ESICM recommendation favouring that strategy. PEEP may recruit collapsed units and prevent end-expiratory collapse, but excessive PEEP can overdistend aerated lung and impair circulation. Evaluate oxygenation, compliance, plateau pressure and haemodynamics together; an oxygenation improvement alone does not establish net benefit.
Apply it
Increasing PEEP improves saturation but causes hypotension and poorer compliance. Reassess recruitment, overdistension and circulatory effects rather than retaining the setting solely because oxygenation improved.
Common pitfall: Do not convert individual physiological reasoning or a recommendation from another organisation into an ESICM endorsement of routine higher PEEP. No recommendation also does not mean that PEEP settings need no individual assessment.
42.How is kidney replacement modality selected in haemodynamic instability?
Kidney replacement modalities differ in the rate and continuity of fluid and solute removal. KDIGO suggests continuous therapy rather than standard intermittent treatment for haemodynamically unstable patients, and for AKI with acute brain injury or increased ICP. Slower, sustained changes can be easier to tolerate physiologically. Modality selection does not settle the prescription: net fluid removal, solute clearance, anticoagulation and monitoring still need individual adjustment to the patient's circulation and treatment goals.
Apply it
A patient needing kidney replacement therapy remains dependent on substantial vasopressor support and has intracranial hypertension. Consider continuous therapy to limit abrupt haemodynamic and osmotic changes, while tailoring net fluid removal to current perfusion and congestion.
Common pitfall: Continuous treatment is not automatically haemodynamically neutral. Excessive net fluid removal can still worsen perfusion, and modality choice should not substitute for careful prescription review.
KDIGO Clinical Practice Guideline for Acute Kidney Injury, 2012
43.When should enteral nutrition begin in a critically ill adult?
ESPEN supports early enteral nutrition, generally within 48 hours, when oral intake is not possible and the gastrointestinal tract can be used safely. Feeding is delayed during uncontrolled shock until haemodynamic and tissue-perfusion goals are achieved; cautious low-dose feeding may then be introduced during stabilisation. The issue is not simply whether a vasopressor is present, but whether perfusion is controlled and feeding is tolerated. Reassess abdominal findings and evolving instability throughout treatment.
Apply it
A ventilated patient cannot eat, has a functioning gastrointestinal tract and is stable on decreasing circulatory support. Start cautious enteral nutrition rather than waiting for extubation, while monitoring tolerance and any recurrence of haemodynamic instability.
Common pitfall: Early feeding does not mean feeding through uncontrolled shock. Conversely, the mere presence of a stable vasopressor infusion does not always require prolonged withholding of nutrition.
ESPEN practical and partially revised guideline: Clinical nutrition in the intensive care unit, 2023
44.Why should nutritional delivery increase progressively in early critical illness?
Early critical illness includes substantial endogenous energy production that nutrition does not immediately suppress. Rapid delivery of full estimated requirements can therefore cause overfeeding, hyperglycaemia and other metabolic complications. ESPEN recommends progressive delivery rather than immediate full feeding, with indirect calorimetry preferred when feasible for energy assessment. Include calories from non-nutritional sources such as propofol and intravenous glucose. The prescription should evolve with illness phase, measured needs and tolerance instead of remaining a fixed admission estimate.
Apply it
A patient receives enteral feed plus substantial propofol and intravenous glucose. Count all energy sources before increasing the feed, and advance delivery progressively rather than adding full estimated nutrition on top of unrecognised non-feed calories.
Common pitfall: An estimated calorie target is not an instruction to deliver the full amount immediately. Ignoring drug-associated and intravenous glucose calories can produce unintended overfeeding.
ESPEN practical and partially revised guideline: Clinical nutrition in the intensive care unit, 2023
45.Why is quantitative train-of-four monitoring needed before extubation?
Residual neuromuscular blockade can impair upper-airway function and ventilation even when a patient appears awake or produces apparently strong movements. ASA guidance recommends quantitative monitoring and confirmation of a train-of-four ratio of at least 0.9 before extubation. Clinical tests and qualitative assessment cannot reliably exclude residual weakness. The ratio measures recovery of the fourth twitch relative to the first, so observing four twitches alone is insufficient to demonstrate adequate recovery.
Apply it
After surgery, a patient follows commands and sustains a head lift, but quantitative train-of-four ratio is 0.72. Treat this as incomplete neuromuscular recovery and continue appropriate support and reversal assessment rather than extubating on clinical appearance alone.
Common pitfall: Four visible twitches do not establish a ratio of 0.9. Alertness and a head lift can coexist with clinically important residual neuromuscular blockade.
2023 ASA Practice Guidelines for Monitoring and Antagonism of Neuromuscular Blockade
46.How does an unrepaired postoperative anastomotic leak change nutrition?
An unrepaired anastomotic leak changes whether the gastrointestinal tract can be used safely for nutrition. ESPEN advises withholding enteral nutrition when reliable feeding access distal to the leak is unavailable; parenteral nutrition may be commenced. The anatomical relationship between the feeding route and the leak is therefore decisive. Assess repair options, distal access, nutritional deficits and the expected period without safe enteral intake, then prescribe progressive support appropriate to the patient's clinical condition.
Apply it
After gastrointestinal surgery, a patient has an unrepaired leak and no usable feeding access beyond it. Withhold enteral feeding through the affected route and assess parenteral support while the surgical and nutritional teams establish a definitive plan.
Common pitfall: A general recommendation for early enteral feeding does not override unsafe postoperative anatomy. Conversely, an anastomotic leak does not establish that every possible distal feeding route is unusable; the actual anatomy and access must be assessed.
ESPEN practical and partially revised guideline: Clinical nutrition in the intensive care unit, 2023
47.How does blockade depth influence reversal choice?
Reversal strategy depends on the neuromuscular blocker and measured depth of blockade. ASA recommends sugammadex over neostigmine for deep, moderate and shallow blockade produced by rocuronium or vecuronium. Neostigmine is a reasonable alternative for minimal blockade, defined by a quantitative train-of-four ratio from 0.4 to below 0.9. Neither drug selection nor administration replaces confirmation of recovery. Identify the agent and objective depth first, then verify the final train-of-four ratio before extubation.
Apply it
A postoperative patient has persistent moderate rocuronium blockade on quantitative assessment. Select reversal appropriate to that agent and depth rather than relying on neostigmine as if minimal recovery were already present, and confirm adequate recovery afterward.
Common pitfall: Reversal drugs are not interchangeable across all agents and blockade depths. Giving a reversal agent does not prove that sufficient recovery has occurred for extubation.
2023 ASA Practice Guidelines for Monitoring and Antagonism of Neuromuscular Blockade
48.How does active postoperative bleeding change interpretation of haemoglobin?
Restrictive transfusion thresholds for haemodynamically stable patients do not define safe waiting points during uncontrolled postoperative haemorrhage. Acute whole-blood loss may initially leave haemoglobin relatively preserved; subsequent fluid shifts and resuscitation alter the measured concentration. Assess ongoing loss, perfusion, haemodynamic trajectory and the need for haemorrhage control together. A value above 7 g/dL cannot exclude a dangerous bleeding episode or establish that blood replacement is unnecessary.
Apply it
A postoperative patient develops hypotension and rapidly increasing bloody drain output while haemoglobin is 9 g/dL. Escalate haemorrhage assessment, control and resuscitation without waiting for the stable-patient threshold.
Common pitfall: Neither a reassuring initial haemoglobin nor a transient blood-pressure response proves that bleeding has stopped.
Practical procedures10%
49.How does waveform capnography support tracheal tube confirmation?
Continuous waveform capnography confirms and monitors tracheal tube placement by demonstrating sustained exhaled carbon dioxide. When sustained exhaled carbon dioxide is absent, urgently exclude oesophageal intubation. Check immediately remediable equipment problems, such as a disconnected sampling line or circuit. If confirmation remains absent, the default response is to remove the tube and ventilate with a facemask or supraglottic airway. If removal is considered dangerous, obtain urgent valid alternative confirmation, such as flexible bronchoscopy demonstrating tracheal rings and the carina. Cardiac arrest alone must never be accepted as reassurance about tube position.
Apply it
After intubation during cardiac arrest, chest movement occurs but no sustained carbon dioxide waveform appears. Continue resuscitation while checking connections and urgently assessing placement. If an immediately correctable equipment fault does not explain the absent waveform, remove the unconfirmed tube and restore ventilation with a facemask or supraglottic airway, unless removal is dangerous and urgent alternative confirmation is pursued.
Common pitfall: Reduced pulmonary blood flow during arrest can produce a low carbon dioxide value despite tracheal placement; this differs from failure to establish sustained exhaled carbon dioxide. Chest movement and auscultation alone cannot safely resolve that failure. Continue waveform monitoring after confirmation because subsequent displacement or circuit disconnection can occur.
Adult Advanced Life Support Guidelines, 2025 — Resuscitation Council UK
50.How is plateau pressure distinguished from peak airway pressure?
Peak airway pressure includes pressure needed to overcome airway resistance and distend the respiratory system. During passive ventilation, an end-inspiratory hold permits measurement of plateau pressure after flow stops, reducing the resistive component. A high peak with a relatively unchanged plateau suggests increased resistance; a high plateau suggests increased elastic load or overdistension. ARDS protective ventilation limits plateau pressure, commonly to no more than 30 cmH2O, while recognising that chest-wall mechanics can influence the measurement.
Apply it
A passively ventilated patient develops peak pressure of 40 cmH2O while plateau remains 24 cmH2O. Investigate increased resistance, including secretions, bronchospasm or tube problems, rather than assuming that alveolar distending pressure has risen to the peak value.
Common pitfall: An inspiratory hold is unreliable during active respiratory effort or a significant leak. Peak pressure alone cannot distinguish increased airway resistance from reduced respiratory-system compliance.
51.Why should ultrasound guide central venous access?
When available and used by trained clinicians, ultrasound guidance reduces attempts and mechanical complications during central venous catheter placement. Real-time imaging helps identify the target vessel, nearby artery, vessel patency and needle trajectory. Its benefit depends on maintaining visualisation and using appropriate technique rather than merely marking the skin beforehand. Ultrasound does not replace asepsis, confirmation of appropriate catheter position or recognition of complications, so procedural planning must integrate anatomical, mechanical and infection-prevention considerations.
Apply it
A patient with difficult neck landmarks requires central venous access. Use real-time ultrasound with sterile equipment and trained technique to identify the vessel and guide needle advancement, rather than repeating blind attempts based on surface anatomy alone.
Common pitfall: Seeing the needle shaft does not guarantee that the tip is safely located. Ultrasound guidance also does not eliminate infection risk or the need for barriers.
Summary of Recommendations: Prevention of Intravascular Catheter-Related Infections — CDC
52.Which insertion precautions reduce central-line infection risk?
CDC recommendations combine hand hygiene, aseptic technique, maximal sterile barriers and appropriate skin antisepsis for central venous catheter insertion. Maximal barriers include a cap, mask, sterile gown, sterile gloves and a full-body sterile drape. Alcoholic chlorhexidine above 0.5% is recommended for skin preparation unless contraindicated, and the antiseptic should dry before insertion. These measures address different routes of contamination; completing one step does not compensate for a breach elsewhere in the procedure.
Apply it
During preparation for a central line, the operator has sterile gloves but only a small drape covers the insertion site. Obtain the complete maximal-barrier setup and allow skin antiseptic to dry before beginning the procedure.
Common pitfall: Sterile gloves alone do not constitute maximal barriers. Ultrasound guidance improves mechanical safety but does not compensate for inadequate skin preparation or a contaminated field.
Summary of Recommendations: Prevention of Intravascular Catheter-Related Infections — CDC
53.How should central-line site selection balance infection and mechanical risk?
CDC recommends balancing infection risk against mechanical complications when choosing a central venous access site. In adults, subclavian placement can reduce infection risk compared with jugular or femoral access for a non-tunnelled catheter, but pneumothorax and other complications matter. Avoid subclavian access in advanced kidney disease or haemodialysis patients because venous stenosis can compromise future access. The preferred site therefore depends on anatomy, bleeding risk, renal access planning and the operator's ability to perform the procedure safely.
Apply it
An adult with advanced kidney disease needs central venous access and may require long-term dialysis. Include preservation of future dialysis access in site selection rather than automatically choosing the subclavian site for its infection-risk advantage.
Common pitfall: The site with a lower infection risk is not always the safest overall choice. Future vascular access and mechanical complications can change the balance.
Summary of Recommendations: Prevention of Intravascular Catheter-Related Infections — CDC
54.How does an external ventricular drain differ from a parenchymal ICP monitor?
An external ventricular drain can measure ventricular pressure and remove cerebrospinal fluid, providing both monitoring and a potential treatment for raised ICP. A parenchymal pressure monitor measures local intracranial pressure but does not drain CSF. Brain Trauma Foundation guidance discusses CSF drainage as an ICP-lowering intervention, with limited-strength evidence supporting selected approaches. Device choice therefore depends on the clinical need, anatomy and procedural risks, rather than assuming all ICP monitors offer the same therapeutic functions.
Apply it
A severe TBI patient needs ICP monitoring and may benefit from CSF diversion. Discuss whether ventricular access is feasible and appropriate, recognising that a parenchymal monitor can provide pressure information but cannot deliver the proposed drainage treatment.
Common pitfall: An ICP number does not imply a drainage capability. The ability to drain CSF also does not eliminate infection, bleeding or monitoring-management risks.
Guidelines for the Management of Severe Traumatic Brain Injury, Fourth Edition
Patient general care10%
55.How do agonal breaths change recognition of cardiac arrest?
Agonal breathing consists of abnormal, often slow or gasping respiratory efforts and does not establish effective circulation. In an unresponsive adult who is not breathing normally, recognise possible cardiac arrest, activate emergency help and begin the appropriate resuscitation response. Healthcare professionals should avoid prolonged attempts to establish certainty before acting. The key discrimination is normal breathing versus abnormal gasping, because mistaking gasps for adequate respiration is a common reason for delayed compressions and defibrillator access.
Apply it
An adult collapses, is unresponsive and makes occasional noisy gasps. Treat the breathing as abnormal, summon the resuscitation response and start CPR according to the adult algorithm rather than waiting for the gasping to stop completely.
Common pitfall: Gasping is not reassuring normal breathing. Prolonged observation for a clearer arrest picture wastes time during which prompt compressions and defibrillator availability are crucial.
Adult Basic Life Support Guidelines, 2025 — Resuscitation Council UK
56.What defines high-quality adult chest compressions?
Adult basic life support recommends a compression rate of 100–120 per minute and depth of 5–6 cm, with full recoil and minimal interruption. These elements work together to generate blood flow during arrest. Excessive speed can reduce depth or recoil, while leaning impairs venous return. Organise rhythm checks, airway work and rescuer changes to protect compression continuity. Quality is therefore a coordinated physiological task, not simply reaching the upper limit of an acceptable compression rate.
Apply it
A rescuer compresses at 140 per minute with shallow depth and incomplete release. Use feedback to restore the recommended rate, adequate depth and full recoil, while arranging a timely rescuer change without a prolonged pause.
Common pitfall: Faster compressions are not necessarily better. Correct average rate cannot compensate for inadequate depth, leaning or long interruptions during other resuscitation tasks.
Adult Basic Life Support Guidelines, 2025 — Resuscitation Council UK
57.How should end-tidal carbon dioxide guide CPR without determining termination alone?
During CPR, end-tidal carbon dioxide reflects interactions among ventilation, metabolism and pulmonary blood flow. A sudden sustained rise may indicate return of spontaneous circulation, while persistently low values should prompt review of compression quality, ventilation, airway position and reversible causes. Capnography provides useful physiological information but is not a standalone rule for stopping resuscitation. Interpret its trend within the full clinical context and coordinate confirmation of circulation without creating unnecessary interruptions in compressions.
Apply it
During otherwise organised CPR, end-tidal carbon dioxide rises abruptly and remains higher. Consider possible return of circulation and coordinate assessment at the appropriate point, while maintaining effective compressions until circulation is confirmed rather than stopping immediately from the trace alone.
Common pitfall: A single low end-tidal value does not establish futility. Excessive ventilation, low flow, equipment problems and the arrest cause can all alter the measurement.
Adult Advanced Life Support Guidelines, 2025 — Resuscitation Council UK
58.How should enhanced mobilisation support ICU recovery?
The focused PADIS update supports enhanced mobilisation and rehabilitation for critically ill adults. Prolonged immobility contributes to weakness and loss of function, so recovery planning should begin during ICU care rather than after discharge. Select activities according to alertness, respiratory and cardiovascular stability, strength and device safety. Progression may range from active bed exercises to sitting, standing and walking. The decision is the safest useful activity today, with repeated reassessment rather than a universal intensity target.
Apply it
An awake ventilated patient is haemodynamically stable and follows commands. Coordinate physiotherapy, nursing and medical assessment for an appropriate mobilisation session, securing the airway and lines and choosing activity that matches present strength and physiological reserve.
Common pitfall: Mechanical ventilation does not automatically prohibit mobilisation. Conversely, an enhanced programme does not justify progressing through new instability or ignoring airway and device safety.
A Focused Update to SCCM PADIS Guidelines for Adult Patients, 2025
59.How do patient preferences guide end-of-life decisions in ICU?
End-of-life decisions should integrate prognosis, treatment burdens, the patient's values and applicable legal requirements. Assess decision-making capacity and involve the patient directly whenever possible; otherwise use valid prior wishes and the appropriate surrogate process. Structured communication should clarify goals, explain uncertainty and distinguish beneficial treatment from burdens unlikely to achieve the patient's aims. Symptom relief remains active care when life-sustaining treatment is limited or withdrawn. Legal authority and procedural requirements vary across jurisdictions.
Apply it
A patient lacks capacity and has documented preferences against prolonged invasive support in irreversible illness. Review their applicability with the team and authorised surrogate, explain prognosis and options, and create a comfort-focused plan consistent with local legal requirements.
Common pitfall: Family involvement does not erase the patient's known wishes. Limiting life-sustaining treatment also does not mean stopping symptom assessment, communication or compassionate bedside care.
ESICM guidelines on end of life and palliative care in the intensive care unit, 2024
60.When should an intravascular catheter be removed or replaced?
CDC recommends promptly removing intravascular catheters that are no longer essential. Daily necessity review reduces avoidable device exposure and associated complications. Do not routinely replace central venous catheters solely to prevent infection, and do not remove a catheter because of fever alone without considering the wider clinical picture. Suspected catheter infection requires a structured assessment of source probability, severity and access needs. The key safety decision is continued justified use, not automatic retention or calendar-based replacement.
Apply it
A recovering patient no longer needs vasopressors or central-only therapy, but the central catheter remains for convenience. Remove it after confirming an adequate alternative plan rather than retaining an unnecessary device or scheduling routine replacement.
Common pitfall: Routine replacement adds procedural risk without establishing an infection-prevention benefit. Fever alone also does not prove the catheter is the source or mandate indiscriminate removal.
Summary of Recommendations: Prevention of Intravascular Catheter-Related Infections — CDC
What to focus on during revision
The following are CertMedbry study suggestions. Use the official outline to check the full scope of your examination.
- Allocate study time broadly in the Part I ratio of 50% disease management, 30% interventions and support, 10% procedures and 10% general care.
- Within disease management, give substantial attention to cardiovascular disorders and infection while retaining renal, neurological, gastrointestinal, respiratory and other-disorder coverage.
- Practise decisions that separate a measurement from an indication: fluid response versus fluid tolerance, ICP versus CPP, glucose correction versus DKA resolution, and haemoglobin thresholds versus clinical need.
- Link every intervention to its physiological aim, evidence-supported boundary, response measure and important harm.
- Supplement this adult selection with the official paediatric competencies, peri-partum conditions, toxicology, haematology/oncology and other syllabus areas not developed here.
- Use the questions to strengthen clinical reasoning and the flashcards to identify gaps that require deeper study.
A practical preparation plan
1. Map the complete official scope
Use the 31/03/2026 handbook and CoBaTrICE competencies to identify every required area. Mark these 60 concepts as a selective adult foundation and schedule the remaining adult, paediatric and cross-cutting competencies.
2. Build mechanism-to-decision explanations
For each concept, explain the physiological mechanism, decisive clinical cue, appropriate action and important boundary aloud. Revisit any answer that relies on a slogan without identifying what changes the decision.
3. Practise calculations and measurement limits
Calculate CPP, PaO2/FiO2, predicted-weight tidal volume and weight-adjusted urine output. Then explain what each number does not establish, such as ARDS diagnosis, fluid need or overall extubation readiness.
4. Complete and analyse the learning test
Answer the 20 questions before reading explanations. For each error, identify the missed cue and explain why the chosen option was tempting. Record a specific correction rather than memorising the answer position.
5. Compare closely related decisions
Contrast fluid responsiveness with tolerance, pressure restoration with perfusion recovery, and glucose correction with ketone clearance. Explain which additional finding would change your action in each case.
6. Use recall to revisit weak domains
Space the flashcards across several sessions and answer before turning them over. Revisit the underlying guideline when a boundary is unclear, and rebalance revision using the official domain weights and your demonstrated gaps.
Use your sample score as a starting point
The free set contains 20 original practice questions. It is a small learning sample, not an official examination or a validated pass prediction. Review each explanation and its source before moving to another topic.
Start the free sampleOfficial sources and updates
- EDIC — ESICM
- European Diploma in Intensive Care Medicine: Exam Guidelines and Regulations, 2026 — 31/03/2026 version
- EDIC I Exam — ESICM
- ESICM guidelines on circulatory shock and hemodynamic monitoring 2025 — UCL Discovery
- New ESICM Guideline on Circulatory Shock and Haemodynamic Monitoring
- Surviving Sepsis Campaign Adult Quick Guide, 2026
- Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026
- Acute Kidney Injury and Acute Kidney Disease — KDIGO
- KDIGO Clinical Practice Guideline for Acute Kidney Injury, 2012
- Coma Guidelines — Brain Trauma Foundation
- Guidelines for the Management of Severe Traumatic Brain Injury, Fourth Edition
- ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies
- ACG Guideline Highlights: Acute Pancreatitis, 2024
- Hyperglycemic Crises in Adults With Diabetes: A Consensus Report, 2024
- Updates in Red Blood Cell Transfusion Thresholds — AABB
- 2023 ASA Practice Guidelines for Monitoring and Antagonism of Neuromuscular Blockade
- ESPEN practical and partially revised guideline: Clinical nutrition in the intensive care unit, 2023
- Summary of Recommendations: Prevention of Intravascular Catheter-Related Infections — CDC
- Adult Advanced Life Support Guidelines, 2025 — Resuscitation Council UK
- Adult Basic Life Support Guidelines, 2025 — Resuscitation Council UK
- A Focused Update to SCCM PADIS Guidelines for Adult Patients, 2025
- ESICM guidelines on end of life and palliative care in the intensive care unit, 2024
- Client Challenge
- Client Challenge
- Sugammadex 100 mg/ml Solution For Injection - Summary of Product Characteristics (SmPC) - (emc) | 14949
- Adult%20tachyarrhythmia%20algorithm%20V3%20March%202026.pdf
- Client Challenge
Confirm current eligibility, fees, scheduling and policies directly with the examination provider. CertMedbry is independent and is not endorsed by these organisations. How we handle content and corrections.